CardioGenics Holdings (CardioGenics Holdings) Price-to-Free-Cash-Flow : N/A (As of Jun. 07, 2024)

CardioGenics Holdings Price-to-Free-Cash-Flow Chart

CardioGenics Holdings Annual Data
	Trend	Jul06	Jul07	Jul08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15
Price-to-Free-Cash-Flow		Get a 7-Day Free Trial					-	-	-	-	-

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CardioGenics Holdings's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, CardioGenics Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Price-to-Free-Cash-Flow falls into.

CardioGenics Holdings Price-to-Free-Cash-Flow Calculation

CardioGenics Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

CardioGenics Holdings's Share Price of today is $0.0001.
CardioGenics Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

CardioGenics Holdings  (OTCPK:CGNH) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

CardioGenics Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description